ArticleCancer medicine2018
Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset.
Article in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed, 4 syntheses or guidelines pooled it, 105 citations in OpenAlex.
- Prevalence of Cervical Cancer Screening in Asia: A Systematic Review and Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2025Pooled it
- Uptake of cervical cancer screening and its associated factors in Africa: an umbrella review of systematic reviews and meta-analyses.BMC public health · 2025Pooled it
- Cervical cancer screening utilization among healthcare professionals in Ethiopia: systematic review and meta-analysis.Frontiers in global women's health · 2025Pooled it
- Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.PloS one · 2021Pooled it
- Assessing the influence of male vaccination on cervical cancer elimination in China under different vaccination coverage scenarios: A modeling study.Human vaccines & immunotherapeutics · 2025Review
- A Novel Method for Predicting Oncogenic Types of Human Papillomavirus.Diagnostics (Basel, Switzerland) · 2025Article
- Cervical cancer screening uptake questionnaire (CCSTQ) for women: instrument development and validation.BMC women's health · 2025Article
- Participation, knowledge, and attitudes toward cervical cancer screening among migrant Burmese women on China-Myanmar border: a cross-sectional study.Preventive medicine reports · 2025Article
- Impact of government-organized screening programs on the economic burden of cervical cancer across five disease courses: a multistage regression and mediation analysis.Cancer biology & medicine · 2025Article
- Charged multivesicular body protein 4C promotes the progression of cervical cancer through the HPV E6/miR‑543 axis.Oncology letters · 2025Article
- [TruScreen Combined With High-Risk Human Papillomavirus Testing vs Thinprep Cytology Test Combined With High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: A Comparative Clinical Study].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025Article
- Optimizing strategy for cervical cancer prevention in china: a comprehensive modeling analysis.Cost effectiveness and resource allocation : C/E · 2025Article
- Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study.The Lancet regional health. Western Pacific · 2025Article
- Prevalence and Risk Factors of Cervical Lesion Among Married Women With Low Socioeconomic Status: A Study Based on a Cervical Cancer Screening Program.International journal of public health · 2025Article
- A bibliometric analysis of artificial intelligence applied to cervical cancer.Frontiers in medicine · 2025Article
- Impact of achieving WHO's 90-70-90 targets on cervical cancer elimination and potential benefits in preventing other HPV-related cancers in China: a modelling study.EClinicalMedicine · 2024Article
- Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study.The Lancet regional health. Western Pacific · 2024Article
- Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022.BMC public health · 2024Article
- Optimising cervical cancer screening during pregnancy: a study of liquid-based cytology and HPV DNA co-test.Epidemiology and infection · 2024Article
- Risk of cervical intraepithelial neoplasia grade 3 or more diagnoses for human papillomavirus16/18-positive women by cytology and co-infection status.Infectious agents and cancer · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Variations in cervical cancer screening rates in China have rarely been studied in depth. This study aimed to investigate cervical cancer screening rates in relation to both individual-level and geographical measures of socioeconomic status (SES). Data were obtained from women aged 21 years or older by face-to-face interviews between August 2013 and July 2014 as part of the Chinese Chronic Diseases and Risk Factors Surveillance. The geographical variables were obtained from the 2010 Chinese population census. The cervical cancer screening rates and 95% confidence interval (CI) were estimated and mapped. Multilevel logistic regression models were fitted. Overall, only 21.4% (95% CI: 19.6-23.1%) of 91,816 women aged ≥21 years reported having ever been screened for cervical cancer and significant geographical variations at both province and county levels were identified (P < 0.01). The cervical cancer screening rates were the lowest among the poor [13.9% (95% CI: 12.1-15.7%)], uninsured [14.4% (95% CI: 10.3-18.4%)], less-educated [16.0% (95% CI: 14.3-17.6%)], and agricultural employment [18.1% (95% CI: 15.8-20.4%)] women along with those residing in areas of low economic status [15.0% (95% CI: 11.8-18.2%)], of low urbanization [15.6% (95% CI: 13.4-17.7%)], and of low education status [16.0% (95% CI: 14.0-18.1%)]. The multilevel analysis also indicated that women with lower individual-level measures of SES residing in areas with low geographical measures of SES were significantly less likely to receive cervical cancer screening (P < 0.0001). Despite the launch of an organized cancer screening program in China, cervical cancer screening rates remain alarmingly low and significant variations based on geographical regions and measures of SES still exist. It is therefore essential to adopt strategies to better direct limited available public resources to priority groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.